关于「药代—药效耦合:知觉阈不是一个数」,《亚知觉色胺动力学与可塑性窗口》给出的定量结论是什么?

结论:效应室模型是药理学的标准工具,而它给出一个对本书主题关键的结论:效应的时程是 \(k_{e0}\) 的性质而不是药代动力学的性质。在完全相同的血浆曲线下,\(k_{e0}\) 从 0.3 降到 0.1 就使「是否越过知觉阈」从「将近四个半衰期在阈上」变为「从未越过」,而 \(k_{e0}\) 只能由效应数据拟合。同一模型给出滞后回线:在同一血浆浓度下下降段的效应远大于上升段,所以不建模滞后的浓度—效应拟合会给出错误的 \(EC_{50}\)。最后,「亚知觉」是一个人群分布而不是一个剂量:在暴露与阈值各有个体差异的人群中,没有任何剂量比例使察觉比例为零,而从 2% 察觉到 25% 察觉之间只有 2.6 倍的余地。要用纯预期解释一个 0.20 个标准差的观测差别,在 40% 猜中率下只需 0.50 个标准差的预期效应,所以设盲完整性必须被测量。

数据口径:本书是教学与研究用的生物数学与方法学讨论,不是医疗建议,也不是任何物质的使用指南。 本书讨论的物质在多数司法辖区受管制;书中不给出任何剂量、质量、产品、来源、途径、合成或疗程:全书的剂量一律以相对于一个未指定参考值的无量纲比值表示,这是第 8 本确立的写法。

English version

对照数据表

下表数字由本章 Python 程序原样打印,可重新运行复现。 程序只用 Python 标准库与结论吻合的打印值: 0.1, 0.20, 0.50, 2.6, 25

Between-person CV: exposure 45%, noticing threshold 60%.
Dose fraction 1.0 is defined as the population MEDIAN noticing exposure.
   dose fraction   proportion noticing (simulated)   (analytic)
            0.05                           0.0000       0.0000
            0.10                           0.0008       0.0005
            0.15                           0.0045       0.0034
            0.20                           0.0138       0.0109
            0.30                           0.0505       0.0430
            0.50                           0.1847       0.1615
            1.00                           0.5379       0.5000
There is no dose fraction at which the proportion is zero. At one tenth of
the median noticing exposure, 0.1% of people still notice something; at
one fifth, 1.1% do. A blind that depends on nobody noticing cannot be
achieved by lowering the amount; it can only be made imperfect to a known
degree, which is why Chapter 8 MEASURES the blind rather than assuming it.
The design question: what proportion noticing can a trial tolerate? If a
fraction f of participants correctly identify their allocation and their
expectancy contributes an effect of size g (in SD units) while the drug
itself contributes nothing, the observed between-arm difference is about
f * g. For an observed 0.20 SD difference to be pure expectancy:
   proportion noticing f   required expectancy effect g (SD)
                    0.05                                   4.00
                    0.10                                   2.00
                    0.20                                   1.00
                    0.40                                   0.50
                    0.60                                   0.33
   At f = 0.40 an expectancy effect of 0.50 SD would suffice, which is
   well within the range reported for open-label expectancy manipulations.

核心公式

\[\frac{dC_e}{dt} = k_{e0}\,(C_p - C_e), \qquad E = \frac{(C_e/EC_{50})^h}{1 + (C_e/EC_{50})^h}.\]
查看完整验算程序
# Chapter 3. "Sub-perceptual" is a distribution across people, not a dose. Two
# sources of variability sit between a dose fraction and whether anyone
# notices anything:
#   (1) pharmacokinetic: exposure per unit dose varies between people
#   (log-normal, CV_pk) (2) pharmacodynamic: the concentration at which a
#   person notices varies (log-normal)
# The program computes, for a range of dose fractions, the proportion of a
# population who would notice an effect, and then asks the design question
# that matters for Chapter 8: at what dose fraction is the proportion noticing
# low enough for a trial to stay blind? Dimensionless; synthetic population;
# fixed seed; standard library only.
import math
import random
from statistics import NormalDist

N = NormalDist()
CV_PK = 0.45        # between-person variability in exposure per unit dose
CV_THR = 0.60       # between-person variability in the noticing threshold
POP = 40000

def lognormal_sigma(cv):
    return math.sqrt(math.log(1.0 + cv * cv))

def proportion_noticing(dose_fraction, rng):
    s_pk = lognormal_sigma(CV_PK)
    s_th = lognormal_sigma(CV_THR)
    hit = 0
    for _ in range(POP):
        exposure = dose_fraction * math.exp(rng.gauss(-s_pk ** 2 / 2, s_pk))
        thresh = math.exp(rng.gauss(-s_th ** 2 / 2, s_th))
        hit += exposure >= thresh
    return hit / POP

def analytic(dose_fraction):
    """Both log-normal with unit median: P(exposure >= threshold) is a normal
    cdf."""
    s = math.sqrt(lognormal_sigma(CV_PK) ** 2 + lognormal_sigma(CV_THR) ** 2)
    return N.cdf(math.log(dose_fraction) / s)

if __name__ == "__main__":
    rng = random.Random(5204)
    print("Between-person CV: exposure {:.0%}, noticing threshold {:.0%}."
          .format(CV_PK, CV_THR))
    print(
        "Dose fraction 1.0 is defined as the population MEDIAN noticing"
        " exposure.\n"
    )
    print("   dose fraction   proportion noticing (simulated)   (analytic)")
    for d in (0.05, 0.10, 0.15, 0.20, 0.30, 0.50, 1.00):
        print("   {:13.2f} {:32.4f} {:12.4f}"
              .format(d, proportion_noticing(d, rng), analytic(d)))

    print(
        "\nThere is no dose fraction at which the proportion is zero. At one"
        " tenth of"
    )
    print(
        "the median noticing exposure, {:.1%} of people still notice"
        " something; at".format(analytic(0.10))
    )
    print(
        "one fifth, {:.1%} do. A blind that depends on nobody noticing"
        " cannot be".format(analytic(0.20))
    )
    print(
        "achieved by lowering the amount; it can only be made imperfect to a"
        " known"
    )
    print(
        "degree, which is why Chapter 8 MEASURES the blind rather than"
        " assuming it."
    )

    print(
        "\nThe design question: what proportion noticing can a trial"
        " tolerate? If a"
    )
    print(
        "fraction f of participants correctly identify their allocation and"
        " their"
    )
    print(
        "expectancy contributes an effect of size g (in SD units) while the"
        " drug"
    )
    print(
        "itself contributes nothing, the observed between-arm difference is"
        " about"
    )
    print("f * g. For an observed 0.20 SD difference to be pure expectancy:")
    print("   proportion noticing f   required expectancy effect g (SD)")
    for f in (0.05, 0.10, 0.20, 0.40, 0.60):
        print("   {:21.2f} {:38.2f}".format(f, 0.20 / f))
    print(
        "\n   At f = 0.40 an expectancy effect of 0.50 SD would suffice,"
        " which is"
    )
    print(
        "   well within the range reported for open-label expectancy"
        " manipulations."
    )
    print(
        "   At f = 0.05 it would need 4.0 SD, which is not plausible. So the"
        " blind"
    )
    print(
        "   integrity measurement is not a formality: it decides whether an"
        " observed"
    )
    print(
        "   difference of this size can be explained without any drug effect"
        " at all."
    )

    print(
        "\nInverting: the dose fraction at which a given proportion notices."
    )
    s = math.sqrt(lognormal_sigma(CV_PK) ** 2 + lognormal_sigma(CV_THR) ** 2)
    print("   target proportion   dose fraction")
    for p in (0.02, 0.05, 0.10, 0.25, 0.50):
        print("   {:17.2f} {:14.4f}".format(p, math.exp(N.inv_cdf(p) * s)))
    d02 = math.exp(N.inv_cdf(0.02) * s)
    print(
        "\n   Reaching 2 % noticing requires about {:.0%} of the median"
        " noticing".format(d02)
    )
    print(
        "   exposure - a fourfold reduction, not the hundredfold that the"
        " word"
    )
    print(
        "   'micro' suggests. Note also how flat this is: between 2 % and"
        " 25 %"
    )
    print(
        "   noticing there is only a factor of {:.1f} in exposure, so a"
        " schedule".format(math.exp(N.inv_cdf(0.25) * s) / d02)
    )
    print(
        "   intended to stay below the threshold has very little margin."
        " Whether"
    )
    print(
        "   anything else survives at that exposure is exactly the open"
        " question,"
    )
    print(
        "   and Chapter 4 shows why the receptor argument does not settle it."
    )

唯一数据源与引用

范雅福(Fan, Y.). (2026). 《亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型》第 3 章「药代—药效耦合:知觉阈不是一个数」(版本 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24019347

DOI: 10.5281/zenodo.24019347 · 阅读本章所在专著 · 5DL-B-054 · v1.0.0 · CC-BY-NC-ND-4.0

BibTeX
@book{fan2026054,
  author    = {Fan, Yafu},
  title     = {Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics},
  year      = {2026},
  publisher = {5D Library},
  edition   = {1.0.0},
  doi       = {10.5281/zenodo.24019347},
  url       = {https://doi.org/10.5281/zenodo.24019347}
}

本书其他章节结论